Back to Search
Start Over
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
- Source :
- American journal of hematologyREFERENCES. 95(3)
- Publication Year :
- 2019
- Subjects :
- Oncology
Male
medicine.medical_specialty
Disease free survival
Combination therapy
Chronic lymphocytic leukemia
Disease-Free Survival
chemistry.chemical_compound
Bridged Bicyclo Compounds
Piperidines
Internal medicine
medicine
Humans
Survival rate
Aged
Aged, 80 and over
Sulfonamides
Venetoclax
business.industry
Adenine
Hematology
Middle Aged
medicine.disease
Bridged Bicyclo Compounds, Heterocyclic
Leukemia, Lymphocytic, Chronic, B-Cell
Survival Rate
Leukemia
Pyrimidines
chemistry
Ibrutinib
Pyrazoles
Female
business
Subjects
Details
- ISSN :
- 10968652
- Volume :
- 95
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- American journal of hematologyREFERENCES
- Accession number :
- edsair.doi.dedup.....e311febaff680b596fa31d7a21ff2964